Resona Asset Management Co. Ltd. raised its stake in shares of Cigna Group (NYSE:CI – Free Report) by 2.8% in the 1st quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 89,074 shares of the health services provider’s stock after purchasing an additional 2,445 shares during the period. Resona Asset Management Co. Ltd.’s holdings in Cigna Group were worth $23,620,000 as of its most recent filing with the Securities & Exchange Commission.
Other institutional investors have also recently made changes to their positions in the company. WPG Advisers LLC lifted its position in shares of Cigna Group by 24.5% in the first quarter. WPG Advisers LLC now owns 203 shares of the health services provider’s stock worth $54,000 after buying an additional 40 shares in the last quarter. Munich Reinsurance Co Stock Corp in Munich grew its holdings in Cigna Group by 163.7% during the 1st quarter. Munich Reinsurance Co Stock Corp in Munich now owns 37,954 shares of the health services provider’s stock valued at $10,124,000 after buying an additional 23,562 shares in the last quarter. Personal CFO Solutions LLC grew its holdings in Cigna Group by 174.1% during the 1st quarter. Personal CFO Solutions LLC now owns 3,297 shares of the health services provider’s stock valued at $880,000 after buying an additional 2,094 shares in the last quarter. CFS Investment Advisory Services LLC bought a new stake in Cigna Group in the 1st quarter worth approximately $374,000. Finally, Navalign LLC increased its stake in Cigna Group by 14.3% in the 1st quarter. Navalign LLC now owns 5,740 shares of the health services provider’s stock worth $1,531,000 after acquiring an additional 719 shares during the last quarter. Hedge funds and other institutional investors own 86.99% of the company’s stock.
Cigna Group Trading Up 0.5%
NYSE CI opened at $291.32 on Friday. The stock has a market cap of $77.06 billion, a PE ratio of 12.35, a PEG ratio of 1.12 and a beta of 0.29. Cigna Group has a 12 month low of $239.51 and a 12 month high of $315.47. The company’s 50-day moving average price is $285.64 and its 200-day moving average price is $279.64. The company has a current ratio of 0.73, a quick ratio of 0.73 and a debt-to-equity ratio of 0.69.
Cigna Group Announces Dividend
The business also recently declared a quarterly dividend, which was paid on Thursday, June 18th. Stockholders of record on Thursday, June 4th were paid a dividend of $1.56 per share. This represents a $6.24 annualized dividend and a dividend yield of 2.1%. The ex-dividend date of this dividend was Thursday, June 4th. Cigna Group’s payout ratio is currently 26.45%.
Wall Street Analysts Forecast Growth
A number of research analysts have recently commented on CI shares. UBS Group increased their target price on Cigna Group from $375.00 to $400.00 and gave the company a “buy” rating in a research report on Friday, May 22nd. Robert W. Baird set a $337.00 price target on shares of Cigna Group in a research report on Friday, May 1st. Cantor Fitzgerald upped their price target on shares of Cigna Group from $325.00 to $340.00 and gave the company an “overweight” rating in a research note on Friday, May 1st. Weiss Ratings reiterated a “hold (c)” rating on shares of Cigna Group in a research report on Monday, June 1st. Finally, The Goldman Sachs Group lifted their price objective on shares of Cigna Group from $335.00 to $340.00 and gave the stock a “buy” rating in a research note on Monday, May 4th. One investment analyst has rated the stock with a Strong Buy rating, fifteen have issued a Buy rating and six have given a Hold rating to the company’s stock. Based on data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average target price of $338.80.
Get Our Latest Stock Analysis on CI
Insider Activity at Cigna Group
In other Cigna Group news, CAO Jamie G. Kates sold 899 shares of the firm’s stock in a transaction on Friday, June 12th. The stock was sold at an average price of $298.61, for a total transaction of $268,450.39. Following the transaction, the chief accounting officer directly owned 2,368 shares in the company, valued at $707,108.48. This trade represents a 27.52% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Also, CEO David Cordani sold 201,878 shares of the company’s stock in a transaction on Tuesday, May 12th. The stock was sold at an average price of $292.82, for a total value of $59,113,915.96. Following the completion of the sale, the chief executive officer owned 34,337 shares of the company’s stock, valued at $10,054,560.34. This represents a 85.46% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders own 0.60% of the company’s stock.
Cigna Group Profile
Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.
In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.
Featured Articles
- Five stocks we like better than Cigna Group
- PriceSmart Stock Eyes $220 as Chile Expansion Fuels Growth
- Dollar Tree’s Turnaround Is Starting to Take Root
- Why Levi’s Digital Strategy Is Paying Off in a Big Way
- Constellation Brands: Beer Growth and Buybacks Mask Stock’s Slump
Receive News & Ratings for Cigna Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna Group and related companies with MarketBeat.com's FREE daily email newsletter.
